Nurse Practitioner, Family · Easthampton, MA
NPI
1710465562
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
238 Northampton St
Easthampton, MA, 01027
Phone (413) 529-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
432 services
Medicare patients, 2024
54
Average age 54
Drug cost, 2024
$230K
662 prescriptions
Company payments, 2025
$370
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn McKenna-Weiss was code 80307 (drug tests), 157 times for 50 patients. In total Kathryn McKenna-Weiss billed 432 services in 7 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80307 Drug Tests | Office | 157 | 50 | $59.40 | $9,325 |
| 99214 Office E&M - Established | Office | 117 | 33 | $82.34 | $9,634 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 83 | 31 | $109.44 | $9,083 |
| 99213 Office E&M - Established | Office | 49 | 26 | $58.33 | $2,858 |
By year: 2022 $17K for 216 services; 2023 $20K for 270 services; 2024 $32K for 432 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 157 | 50 | $59.40 | $9,325 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 83 | 31 | $109.44 | $9,083 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn McKenna-Weiss prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 309 prescriptions and refills. In total Kathryn McKenna-Weiss wrote 662 Medicare prescriptions that cost $230K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 309 | 309 | 81 | $22K |
| Sublocade Buprenorphine | 82 | 82 | 14 | $169K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 40 | 40 | 17 | $14K |
| Clonazepam Generic | 38 | 38 | Under 11 | $297 |
| Buprenorphine Hcl Generic | 27 | 27 | Under 11 | $291 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 25 | 27 | Under 11 | $185 |
| Clonidine Hcl Generic | 21 | 21 | Under 11 | $62.38 |
| Hydroxyzine Hcl Generic | 17 | 17 | Under 11 | $199 |
Brand drugs: 139 claims; generic drugs: 523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn McKenna-Weiss $370 ($370 in general payments such as food, travel and fees) from 4 companies. The largest payer was Indivior Inc. with $241.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.